Evidence map›Paper›PMID 26685315›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2016

Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.

Andrew P Fontenot, Michael T Falta, John W Kappler, Shaodong Dai, Amy S McKee

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Interleukin-1 signaling and CD4Frontiers in immunology · 2025
    Article
  4. Review
  5. Article
  6. [Sarcoidosis and berylliosis].Der Internist · 2022
    Review
  7. Article
  8. Pulmonary Macrophage Cell Death in Lung Health and Disease.American journal of respiratory cell and molecular biology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Environmental Risk Factors for Sarcoidosis.Frontiers in immunology · 2020
    Review
  14. Review
  15. Article
  16. Translational research in pulmonary fibrosis.Translational research : the journal of laboratory and clinical medicine · 2019
    Review
  17. Article
  18. Mechanisms of Adverse Local Tissue Reactions to Hip Implants.Frontiers in bioengineering and biotechnology · 2019
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Andrew P FontenotDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; andrew.fontenot@ucdenver.edu.
Michael T FaltaDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045;ORCID http://orcid.org/0000-0002-0835-6904
John W KapplerDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; Howard Hughes Medical Institute, National Jewish Health, Denver, CO 80206; and Department of Biomedical Research, National Jewish Health, Denver, CO 80206.
Shaodong DaiDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045; Department of Biomedical Research, National Jewish Health, Denver, CO 80206.ORCID http://orcid.org/0000-0003-4760-2773
Amy S McKeeDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045;
University of Colorado Anschutz Medical Campus · USHoward Hughes Medical Institute · USNational Jewish Health · US

Funding

Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
T Cells in Beryllium Sensitization and DiseaseP01ES011810 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI NEWMAN, LEE S · 2002 to 2013
$14.0M
PATHOGENIC T CELLS IN CHRONIC BERYLLIUM DISEASER01HL062410 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 1998 to 2017
$5.7M
Interactions between antigen-specific effector and regulatory T cells in beryllium-induced diseaseR01ES025534 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2016 to 2020
$2.1M
Molecular Basis of T Cell Recognition of Metal IonsR01ES025797 · NIEHS · UNIVERSITY OF COLORADO DENVER · PI DAI, SHAODONG · 2015 to 2019
$1.8M
Patient-Oriented Research in Immunologic Lung Disease.K24HL102245 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2010 to 2020
$1.4M
T Cells in Beryllium Sensitization and DiseaseR01HL092997 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2009 to 2009
$148k
NCATS NIH HHS UL1 TR000154NHLBI NIH HHS HL62410NHLBI NIH HHS HL92997NHLBI NIH HHS K24 HL102245NHLBI NIH HHS R01 HL062410NHLBI NIH HHS R01 HL092997NIEHS NIH HHS ES011810NIEHS NIH HHS ES25797NIEHS NIH HHS P01 ES011810NIEHS NIH HHS R01 ES025534NIEHS NIH HHS R01 ES025797
6 · The paper itself

Abstract

Chronic beryllium (Be) disease is a granulomatous lung disorder that results from Be exposure in a genetically susceptible host. The disease is characterized by the accumulation of Be-responsive CD4(+) T cells in the lung, and genetic susceptibility is primarily linked to HLA-DPB1 alleles possessing a glutamic acid at position 69 of the β-chain. Recent structural analysis of a Be-specific TCR interacting with a Be-loaded HLA-DP2-peptide complex revealed that Be is coordinated by amino acid residues derived from the HLA-DP2 β-chain and peptide and showed that the TCR does not directly interact with the Be(2+) cation. Rather, the TCR recognizes a modified HLA-DP2-peptide complex with charge and conformational changes. Collectively, these findings provide a structural basis for the development of this occupational lung disease through the ability of Be to induce posttranslational modifications in preexisting HLA-DP2-peptide complexes, resulting in the creation of neoantigens.

Indexed as

BerylliosisBerylliumCD4-Positive T-LymphocytesGenetic Predisposition to DiseaseHLA-DP beta-ChainsHumansHypersensitivityLungProtein Processing, Post-TranslationalReceptors, Antigen, T-CellBerylliumHLA-DPB1 antigenHLA-DP beta-ChainsHLA-DPw2 antigenReceptors, Antigen, T-Cell

Identifiers

PMID26685315
PMCPMC4685955
OpenAlexW2218178371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.